Nav: Home

A new way to do metabolic engineering

November 28, 2017

A novel method developed by a group of researchers at the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois could change the way metabolic engineering is done.

Researchers from the IGB's Biosystems Design research theme, including Steven L. Miller Chair of Chemical and Biomolecular Engineering Huimin Zhao, recently published a paper in Nature Communications outlining their new method, which could make the metabolic engineering process more efficient.

Metabolic engineering involves engineering microorganisms to produce value-added products such as biofuels and chemicals. This is achieved by changing or deleting the expression of genes to modify the microorganism's genome. In this process, several targets in the genome are modified in order to achieve specific goals.

"We can easily find several metabolic engineering targets to improve the desired phenotype," said Jiazhang Lian, a visiting research associate at the IGB who is a co-author of the paper. "How to combine these beneficial genetic modifications is one of the biggest challenges in metabolic engineering."

Traditionally, researchers test these targets individually in a series of time-consuming steps. These steps limit productivity and the yield of the final product -- two crucial components in the metabolic engineering process.

The researchers decided to create a method that combines all of these steps and executes them simultaneously, making the process faster and easier.

They based this method on the CRISPR system, a method of genetic manipulation that uses a set of DNA sequences to modify genes within a cell.

This system uses three genetic manipulations that are frequently used in metabolic engineering: transcriptional activation, transcriptional interference, and gene deletion.

By using these manipulations simultaneously, scientists can explore different combinations of manipulations and discover which combination is best.

"We can now work with 20 targets," Zhao said. "We can implement all of these (manipulations) for each target in a combinatorial manner to find out which combination actually will give us higher productivity or yield of the final product."

The researchers tested the method in a species of yeast that is used in winemaking, baking, and the production of biofuels. They showed that using this method could improve the production of a specific product.

Their system, called CRISPR-AID, will allow researchers to easily explore all the possible target combinations. But the key is to find the optimal combination.

"If we compare metabolic engineering to a basketball team, we cannot build a strong team by simply putting the best players together," Lian said. "Instead, we should try to find those who can collaborate and work synergistically."

Their new system opens up thousands -- even millions -- of possibilities, which presents another logistical challenge.

They plan to find the best combinations by developing a high throughput screening method or using a robotic system such as the iBioFAB, a system located in the IGB that automatically produces synthetic biosystems.

"I believe the combination of CRISPR-AID with high throughput screening and iBioFAB will significantly advance the metabolic engineering field in the near future," Lian said.

Zhao hopes to test their method on other organisms, using the same engineering principles but modifying the protocol for different organisms.

Eventually, they hope to extend to the genome scale -- to be able to test all the genes in an organism at once -- which would be a considerable leap in the field of metabolic engineering.

"If we can do that, we can make it truly modularized and also standardize the procedure," Zhao said. "Then we really increase the throughput and the speed of metabolic engineering."

Several research efforts aim to engineer microorganisms for the production of biofuels and chemicals, so any tools that can speed up the process are significant. Zhao believes this is true for their method.

"It's not just an incremental improvement," he said. "It's a new way to do metabolic engineering."
-end-


Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign

Related Genome Articles:

Deciphering the walnut genome
New research could provide a major boost to the state's growing $1.6 billion walnut industry by making it easier to breed walnut trees better equipped to combat the soil-borne pathogens that now plague many of California's 4,800 growers.
Illuminating the genome
Development of a new molecular visualisation method, RNA-guided endonuclease -- in situ labelling (RGEN-ISL) for the CRISPR/Cas9-mediated labelling of genomic sequences in nuclei and chromosomes.
A genome under influence
References form the basis of our comprehension of the world: they enable us to measure the height of our children or the efficiency of a drug.
How a virus destabilizes the genome
New insights into how Kaposi's sarcoma-associated herpesvirus (KSHV) induces genome instability and promotes cell proliferation could lead to the development of novel antiviral therapies for KSHV-associated cancers, according to a study published Sept.
Better genome editing
Reich Group researchers develop a more efficient and precise method of in-cell genome editing.
Unlocking the genome
A team led by Prof. Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells.
Why do we need one pair of genome?
Scientists have unraveled how the cell replication process destabilizes when it has more, or less, than a pair of chromosome sets, each of which is called a genome -- a major step toward understanding chromosome instability in cancer cells.
A new genome for regeneration research
The first complete genome assembly of planarian flatworm reveals a treasure trove on the function and evolution of genes.
Decoding the Axolotl genome
The sequencing of the largest genome to date lays the foundation for novel insights into tissue regeneration.
The Down's syndrome 'super genome'
Only 20 percent of foetuses with trisomy 21 reach full term.
More Genome News and Genome Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.